Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tao Synergies ( (TAOX) ) has shared an update.
On August 28, 2025, Jonathan Schechter and Dr. Alan Tuchman resigned from their positions on the board of directors at TAO Synergies Inc., with Tuchman continuing as Chief Medical Officer. Subsequently, Robert Ephron was appointed to the board on August 29, 2025, bringing extensive experience in advertising and sales. Additionally, the company engaged Joseph Jacks as an advisor to enhance its digital asset treasury strategy, focusing on the intersection of decentralized AI and cryptocurrencies. Jacks, a leading figure in the Bittensor ecosystem, is expected to contribute significantly to TAO Synergies’ initiatives, potentially impacting its operations and market positioning.
More about Tao Synergies
TAO Synergies Inc. is a digital asset treasury company that focuses on the convergence of cryptocurrency and artificial intelligence. It is the first pure-play public company dedicated to acquiring TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI. The company’s strategy involves staking TAO for revenue generation and capital appreciation, aiming to create significant value for shareholders.
Average Trading Volume: 1,071,801
Technical Sentiment Signal: Buy
Current Market Cap: $22.82M
See more insights into TAOX stock on TipRanks’ Stock Analysis page.